Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in CATALYST PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 70,709 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $1.8M as of 2026-Q1. The position was increased (+125.3% shares). CPRX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.8M
Current Shares
70,709
Total Value Change
+$975,264
Total Shares Change
+20,645
Other major holders of CPRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 70,709 |
+125.3% |
| $1.8M |
| 0.0% |
| $23.92 |
42 |
| 2025-Q4 | Decreased | 31,388 | -12.0% | $732,596 | 0.0% | $23.29 | 0 |
| 2025-Q3 | Decreased | 35,680 | -79.3% | $702,896 | 0.0% | $19.55 | 0 |
| 2025-Q2 | Decreased | 172,421 | -6.3% | $3.7M | 0.0% | $21.78 | 0 |
| 2025-Q1 | Increased | 184,085 | +44.2% | $4.5M | 0.0% | $24.69 | 36 |
| 2024-Q4 | Decreased | 127,679 | -16.7% | $2.7M | 0.0% | $21.07 | 0 |
| 2024-Q3 | Increased | 153,250 | +206.1% | $3M | 0.0% | $19.56 | 43 |
| 2024-Q2 | Decreased | 50,064 | -44.4% | $775,491 | 0.0% | $15.49 | 0 |